Collegium Pharmaceutical (COLL) Payables (2014 - 2026)

Collegium Pharmaceutical has reported Payables for 13 years, with the latest figure at $9.2 million in Q2 2026.

• On a quarterly basis, Payables fell 15.14% year-over-year to $9.2 million in Q2 2026; TTM through Jun 2026 was $9.2 million, a 15.14% decrease from a year earlier, with the FY2025 full-year figure at $10.7 million, up 170.95% from the prior year.
• Payables was $9.2 million for Q2 2026 at Collegium Pharmaceutical, up from $6.8 million in the prior quarter.
• The five-year high for Payables was $17.9 million in Q1 2025, with the low at $2.4 million in Q2 2024.
• Average Payables over 5 years is $6.6 million, with a median of $6.3 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Payables slumped 63.48% in 2023, then soared 351.49% in 2025.
• Over 5 years, Payables stood at $3.5 million in 2022, then soared by 148.77% to $8.7 million in 2023, then tumbled by 54.74% to $3.9 million in 2024, then soared by 170.95% to $10.7 million in 2025, then retreated by 13.3% to $9.2 million in 2026.
• The last three Payables figures came in at $9.2 million (Q2 2026), $6.8 million (Q1 2026), and $10.7 million (Q4 2025), per Business Quant data.